Older patients in England are less likely to be offered psychological therapy for depression, smoking cessation support, or surgery for colon cancer than younger patients, even when they are healthy enough to benefit. This research matters because it reveals that age-based inequalities in healthcare access persist across multiple conditions, and that official guidance from NICE often fails to address whether age should affect treatment decisions. The team found that primary care doctors prescribe antidepressants to older patients more readily than they refer them for talking therapies, and that older smokers receive fewer offers of nicotine replacement despite being less addicted. For colon cancer, older patients undergo surgery and chemotherapy less often, though this gap may be narrowing. If these findings change practice, commissioners and clinicians could monitor referral patterns by age and adjust protocols to ensure that healthy older people are not excluded from effective treatments based on age alone. The work also highlights a need for NICE guidelines to state explicitly whether age influences cost-effectiveness, removing ambiguity that currently allows age-based rationing to go unexamined.
View original technical description
We have explored how older people may or may not experience “ageism” using several different approaches. We examined the published academic literature to see how other researchers looked at whether health services and public health care was provided equitably. Much of the research had limitations, often because it used routine data which did not have all the relevant information. Some researchers may have over-interpreted their findings as evidence of ageism when in fact this may or may not be the case in some published papers. We were able to highlight some common issues that we believe need to be considered to improve future research. We then looked at how age was considered by the English National Institute for Health & Care Excellence (NICE) when producing their guidelines. Whilst age was often mentioned, usually in relation to the epidemiology of the condition, there was often no explicit recommendation concerning whether age did or did not affect the cost-effectiveness of any intervention. This left ambiguity for commissioners and providers. Similarly, lack of evidence should be a motivating factor for future research. We then looked at three case studies to see how age may influence access to care. We found that primary care doctors diagnose increasing depression in older people and offer conventional anti-depressant therapies, but the oldest age groups with new depression diagnoses and symptoms have fewer recorded referrals to psychological therapies, and were more likely to be treated with psychotropic drugs, which may or may not have been the most appropriate therapy. This suggests potential inequalities in access to psychological therapies. We also found that older smokers, despite being less addicted to nicotine, were less likely to be offered smoking cessation therapies such as nicotine replacement and counselling. Finally we found that older patients with colon cancer were less likely to receive surgery and/or chemotherapy, though there was some evidence that this gap may be reducing over time. Whilst some of these differences may reflect patient preferences and/or co-morbidity, it is important to ensure that healthy older people who are willing to undertake these treatments are not excluded merely on the basis of their age. This body of work collectively highlights the need to carefully consider are the potential reasons for inequitable access to care among older people and the need for careful monitoring to ensure services are sensitive to the needs of the older population.
NIHR School for Public Health Research - Public Health
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.
Is something wrong? Let us know